Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) currently has a daily average trading volume of 2.73M but it saw 1709611 shares traded in last market. With a market cap of 603.54M USD, the company’s current market price of $2.37 came rising about 7.24 while comparing to the previous closing price of $2.21. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.03 and as low as $1.66.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Robert W. Baird which downgraded the stock as “Neutral” in its note to investors issued on February 26, 2025, recommending a price target of between $9 and $3 for it. Goldman also issued its recommendations for the stock as it downgraded the price target for the stock is $4.25.
Over the week, MRVI’s stock price is moving 5.33% up while it is 14.49% when we observe its performance for the past one month. Year-to-date it is -56.51% down and over the past year, the stock is showing a downside performance of -78.16%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.07 while estimate for next year EPS is -0.28. In next quarter, company is expected to be making quarterly sales of $50M as analysts are expecting the sales for current fiscal year at $194.72M and seeing the company making $215.55M in sales next year. Moreover, analysts are in estimates of $47.46M for current-quarter revenue.
Currently, Maravai LifeSciences Holdings Inc’s total number of outstanding shares is 143.96M with 1.97% of that held by the insiders while 90.36% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -26.20% and return on equity (ROE) at -45.75%. Stock’s beta reads 0.28. Stock has a price to book (P/B) ratio of 1.13 while price to sale or P/S ratio amounts to 2.50. Its return on asset (ROA) is -13.53% on average.
